✦ LIBER ✦

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: Labetalol

✍ Scribed by William Frishman; Stanley Halprin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of the new beta-ad

✍ William Frishman 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 532 KB

Clinical pharmacology of the new beta-ad

✍ William Frishman 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 828 KB

Clinical pharmacology of the new beta-ad

✍ William Frishman; Ralph Silverman; Joel Strom; Uri Elkayam; Edmund Sonnenblick 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 736 KB

Clinical pharmacology of the new beta-ad

✍ Stanley Halprin; William Frishman; Marc Kirschner; Joel Strom 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Clinical pharmacology of the new beta-ad

✍ William Frishman; Richard Davis; Joel Strom; Uri Elkayam; Morris Stampfer; Hille 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Clinical pharmacology of the new beta-ad

✍ William Frishman; John Kostis; Joel Strom; Maryhelen Hossler; Uri Elkayam; Susan 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 268 KB